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Abstract
Background: Before trans-catheter aortic valve implantation (TAVI), assessment of cardiac function and accurate
measurement of the aortic root are key to determine the correct size and type of the prosthesis. The aim of this
study was to compare cardiovascular magnetic resonance (CMR) and trans-thoracic echocardiography (TTE) for the
assessment of aortic valve measurements and left ventricular function in high-risk elderly patients submitted to
TAVI.
Methods: Consecutive patients with severe aortic stenosis and contraindications for surgical aortic valve
replacement were screened from April 2009 to January 2011 and imaged with TTE and CMR.
Results: Patients who underwent both TTE and CMR (n = 49) had a mean age of 80.8 ± 4.8 years and a mean
logistic EuroSCORE of 14.9 ± 9.3%. There was a good correlation between TTE and CMR in terms of annulus size
(R
2 = 0.48, p < 0.001), left ventricular outflow tract (LVOT) diameter (R
2 = 0.62, p < 0.001) and left ventricular
ejection fraction (LVEF) (R
2 = 0.47, p < 0.001) and a moderate correlation in terms of aortic valve area (AVA) (R
2 =
0.24, p < 0.001). CMR generally tended to report larger values than TTE for all measurements. The Bland-Altman
test indicated that the 95% limits of agreement between TTE and CMR ranged from -5.6 mm to + 1.0 mm for
annulus size, from -0.45 mm to + 0.25 mm for LVOT, from -0.45 mm
2 to + 0.25 mm
2 for AVA and from -29.2% to
13.2% for LVEF.
Conclusions: In elderly patients candidates to TAVI, CMR represents a viable complement to transthoracic
echocardiography.
Keywords: cardiovascular magnetic resonance, transcatheter aortic valve implantation, trans-thoracic
echocardiography
Background
Aortic stenosis is one of the most common heart diseases
worldwide, especially in the elderly [1]. In recent years,
transcatheter aortic valve implantation (TAVI) has
emerged as a valuable alternative to surgical aortic valve
replacement in patients at high surgical risk because of
age and/or comorbidities [2,3]. Before TAVI, global assess-
ment of cardiac function and accurate measurement of the
aortic root are key to determine the correct size and type
of the prosthesis [4].
Trans-thoracic echocardiography (TTE) is the recom-
mended method for the preliminary assessment of aortic
stenosis and left ventricular function. TTE provides an
appraisal of aortic root sizes, stenosis severity and left
ventricular function [5,6]. However, TTE is limited by
poor acoustic window and inter-observer variability. The
use of trans-esophageal echocardiography (TEE) allows
a more precise measurement but, being a semi-invasive
technique [7], it is often poorly tolerated by elderly
patients. In addition, accurate definition of the valve
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are heavily calcified. Therefore, in the screening phase
for assessing the eligibility to TAVI, increasing emphasis
has been given to the use of non-invasive, real time,
three-dimensional imaging techniques such as 3-dimen-
sional echocardiography, multidetector row computer
tomography (MDCT) and cardiovascular magnetic reso-
nance (CMR) [8,9]. Many validation studies of MDCT
versus echocardiography have been published [10-13].
Importantly, while the high spatial resolution of MDCT
enables accurate quantification of the aortic valve area,
the use of iodinated contrast media may limit its appli-
cation in the elderly population.
Recently, CMR has been increasingly used for the
assessment of aortic valve area in patients with aortic
stenosis [14-16]. CMR is a non invasive, radiation-free
imaging modality which allows not only a detailed visua-
lization of cardiac structures, but also functional assess-
ment including wall motion analysis, quantification of
cardiac function and myocardial tissue characterization.
The steady-state free precession (SSFP) techniques allow
direct visualization of the aortic valve area for planime-
try in any chosen plane with excellent image quality. To
d a t e ,h o w e v e r ,n oe x h a u s t i v ed a t ao nt h eu s eo fC M R
prior to TAVI have been published. The aim of this
study was to compare CMR and TTE for the assessment
of aortic valve measurements and left ventricular func-
tion in high-risk elderly patients submitted to TAVI.
Methods
Study Population and Design
A total of 103 consecutive patients with severe aortic
stenosis and high risk and/or contraindications for sur-
gical aortic valve replacement were screened from April
2009 to January 2011. Clinical outcomes of a proportion
of patients undergoing TAVI have been reported else-
where [17]. Exclusion criteria for this study were general
contraindications to CMR [18]. The institutional ethics
committee approved the study protocol and all patients
gave informed consent.
Patients were imaged with TTE and CMR (within 3 to
5 days from TTE), whenever feasible. The following
measurements were obtained with each imaging techni-
que: 1) aortic root sizes (annulus, sinus, sinotubular
junction, ascending aorta); 2) aortic valve area; 3) aortic
peak velocity; 4) left ventricular morphology and
function.
Two-dimensional trans-thoracic echocardiography
Patients underwent preoperative TTE with an Acuson
Sequoia (Siemens C 512 System Images). All examina-
tions were stored on CD and analyzed by the same
experienced echocardiographer. Aortic annulus, sinus of
Valsalva and sinotubular junction were sized using bi-
dimensional measurement during the diastole in the
long parasternal axis. Measurements were performed
between the insertions of the right and non-coronary
leaflets to the aortic annulus and the mean value from
three consecutive measurements was used. The ascend-
ing aorta diameter was measured in the same projection
at a distance of 35 mm from the aortic annulus; the
measurement was performed from the beginning of the
anterior wall up to the end of the posterior wall of the
aorta.
The left ventricular outflow tract (LVOT) diameter
was measured in mid-systole in the para-sternal long-
axis view (Figure 1A) proximally to the position of the
pulse wave Doppler data (5 mm below above valve),
then converted to LVOT area (ALVOT) according to the
following equation: A = Π r
2. Peak velocities and velo-
city time integral (Figure 1B and 1C), calculated with
the use of the resident software at the time of imaging,
were used to calculate pressure gradients according to
the modified Bernoulli equation (ΔP=4 V
2)a n da o r t i c
valve area (AVA) was obtained according to the conti-
nuity equation approach [AVA = ALVOT (VTILVOT/VTI-
valve)]. End-diastolic and end-systolic left ventricular
volumes were determined using the biplane Simpson’s
method according to the recommendation of the Ameri-
can Society of Echocardiography [5]. Left ventricular
ejection fraction (LVEF) was calculated as (end-diastolic
volume - end-systolic volume)/end-diastolic volume. All
calculations were blinded to the CMR data.
Cardiovascular Magnetic Resonance
All CMR studies were performed with a Philips Achieva
1.5 Tesla Magnetic Resonance Imaging scanner with a
5-element, phased-array coil (Philips Healthcare, Best,
The Netherlands). To assess ventricular function, cine
images of the entire left ventricle were acquired using
an ECG-gated balanced SSFP pulse sequence. Following
this step, an intravenous bolus dose of 0.2 mmol/kg
body weight of gadobutrol (Gadovist, Bayer Schering
Pharma, Berlin, Germany) was administered at a rate of
3 ml/s by a power injector (Medrad Spectris Solaris,
Medrad, USA). Ten minutes after gadolinium injection,
a ‘Look Locker’ sequence was performed to obtain the
most appropriate inversion time (TI) to null the signal
intensity of normal myocardium. Late gadolinium
enhancement (LGE) images were then acquired using
the following images parameters: fast gradient echo,
repetition time (TR) 6.1 ms, echo time (TE) 3 ms, flip
angle (FA) 25°, field of view (FOV) 320 mm, slices thick-
ness 10 mm, acquired in the left ventricular (LV) short
axis over 2 RR intervals and no interslice gap. The CMR
images were analysed off-line using a commercial soft-
ware (Philips Medical Systems Extended MK Word
Space Version 2.6.3.1) by an experienced observer
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assessment of left ventricular function, the end-diastolic
and end-systolic cine frames were identified for each
slice and the endocardial and epicardial borders were
manually traced. The end-diastolic and end-systolic
volumes were then calculated using the Simpson’sr u l e
(i.e. sum of cavity sizes across all continuous slices). As
per echocardiography, LVEF was calculated as (end-dia-
stolic volume - end-systolic volume)/end-diastolic
volume. The LGE was evaluated on the basis of visual
assessment in short-axis slices. LGE was further charac-
terized by spatial location, pattern, and LGE quantifica-
tion (1-25%, 25-50%, 50-75%, > 75%) [19].
For aortic valve visualisation and measurement, ECG
gating and parallel imaging were used, with SSFP cine
images acquired during expiratory breath-holds. Cine
series of the LV outflow tract in two orthogonal planes
(oblique transverse and oblique coronal: Figures 1D and
1E) were obtained in all patients to visualize the systolic
jet originating from the stenotic valve. Imaging planes
for planimetry were chosen perpendicular to the steno-
tic jet, as deduced from the area of signal loss due to
turbulent flow at valve orifice level. Serial short-axis
cines were acquired (5-mm slice thickness) with no gap
until the entire aortic root was imaged. In the cross-sec-
tional planes, planimetry of the AVA was performed in
all systolic images to determine the maximum AVA and
amplitude (Figure 1F). Using the same planes on the
aortic valve, images were acquired with through-plane
velocity encoding. The imaging parameters were as fol-
lows: TR 5 ms, TE 3 ms, reconstruction matrix 256, FA
12°, recon voxel size 1.25 mm
2; slice thickness = 8 mm;
velocity encoding value (venc) ≥ 150 cm/s (with conco-
mitant gradient correction). In the sagittal and coronal
LVOT planes, end diastolic measurements were made at
3 levels: 1) the level of the aortic annulus; 2) the level of
the maximum diameter across the sinuses; 3) at the
sinotubular junction and 4) at the ascending aorta.
LVOT was measured in mid-systole at 1 cm to the aor-
tic root.
Statistical Analysis
Quantitative data were presented as mean ± standard
deviations and were compared using the Student t test.
Figure 1 Aortic valve area measurement by trans-thoracic echocardiography (TTE) and cardiovascular magnetic resonance (CMR).
Aortic valve area measured by continuity equation TTE approach: Left ventricular outflow tract (LVOT) diameter (A); transaortic peak velocity (B);
aortic velocity-time integral (C). Oblique sagittal view of the aortic outflow tract, with the CMR slice position indicated by three white lines
orthogonal to the stenotic jet (D). Oblique transaxial view of the aortic outflow tract, with CMR slice position indicated by three white lines (E).
Cross-sectional view of a severely stenotic aortic valve; the white line denotes the aortic valve area (F).
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tages. The correlation between CMR and TTE was ana-
lysed by simple linear regression with 95% confidence
intervals (CI). Agreement was established by the Bland-
Altman test. A two-sided p value of < 0.05 was consid-
ered to indicate statistical significance. All data were
processed using the Statistical Package for Social
Sciences, version 15 (SPSS, Chicago, IL, USA).
Results
Of 103 patients screened, 53 did not undergo CMR for
the reasons listed in Figure 2. One patient did not
undergo TTE due to a poor acoustic window and was
further excluded from this analysis. Patients who under-
w e n tb o t hT T Ea n dC M R( n=4 9 )h a dam e a na g eo f
80.8 ± 4.8 years and a mean logistic EuroSCORE of 14.9
± 9.3%. All patients were in NYHA class III-IV and 33%
of them were previously hospitalized for congestive heart
failure (Table 1). All patients well tolerated both the TTE
and CMR examinations. The images quality was diagnos-
tic in 100% of exams. Gadolinium was not used in three
patients due to severe renal failure (creatinine clearance
< 30 ml/min). Evidence of LGE was present in 17 (37%)
of 46 cases. Causes for LGE were ischemic in 14 cases,
non-ischemic in 2 cases and mixed in 1 case. Three
patients with an ischemic LGE pattern had no history of
previous myocardial infarction. No clinical adverse event
was recorded during performance of TTE or CMR.
The mean velocity aortic peak and regurgitation frac-
tion by CMR were 3.9 ± 0.8 m/s and 11.7 ± 8.9%,
respectively. Trans-aortic maximum and mean gradient
evaluated by TTE were 92.1 ± 24.5 mmHg and 55.9 ±
16.2 mmHg with one (2%) case of severe aortic regurgi-
tation and 8 (16%) cases of moderate regurgitation.
There was a good correlation between TTE and CMR in
terms of annulus size (y = 7.15 + 0.60x, R
2 = 0.48, p <
0.001, Figure 3A), LVOT (y = 7.37 + 0.61x, R
2 =0 . 6 2 ,p
< 0.001, Figure 3B) and LVEF (y = 23.98 + 0.47x, R
2 =
0.47, p < 0.001, Figure 3C) and a moderate correlation
in terms of AVA (y = 0.29 + 0.47x, R
2 = 0.24, p < 0.001,
Figure 3D) and peak velocity (y = 3.00 + 0.44x, R
2 =
0.28, p < 0.001) (Table 2).
However, CMR generally tended to report larger
values than TTE for all measurements, including annu-
lus size (absolute difference + 2.3 mm, relative differ-
ence + 11%), LVOT (absolute + 0.5 mm, relative
difference + 3%), LVEF (absolute difference + 8%, rela-
tive difference + 15%), AVA (absolute difference 0.10
mm
2,r e l a t i v ed i f f e r e n c e1 6 % ) and peak velocity (abso-
lute difference 0.8 m/s, relative difference + 21%) (Table
3). The Bland-Altman test indicated that the 95% limits
of agreement between TTE and CMR ranged from -5.6
mm to + 1.0 mm when assessing annulus size (Figure
4A), from -0.45 mm to + 0.25 mm when assessing
LVOT (Figure 4B), from -0.45 mm
2 to + 0.25 mm
2
when assessing AVA (Figure 4C), from -29.2% to 13.2%
when assessing LVEF (Figure 4D) and from -0.64 m/s to
+ 2.18 m/s when assessing peak velocity.
Figure 2 Study flow chart. Reasons for excluding patients from
cardiovascular magnetic resonance or trans-thoracic
echocardiography.
Table 1 Patients Characteristics
Patients 49
Male, n (%) 21 (42.9)
Age, (mean ± DS) 80.8 ± 4.8
Log EuroScore, (mean ± DS) 14.9 ± 9.3
BMI, (mean ± DS) 27.6 ± 5.2
Symptoms
Syncope, n (%) 11 (22.4)
Unstable Angina, n (%) 16 (32.7)
Hospitalization for heart failure, n (%) 16 (32.7)
Dyspnoea, n (%) 42 (85.7)
Risk Factors
Diabetes, n (%) 7 (14.3)
Hypercholesterolemia, n (%) 21 (42.9)
Smoker, n (%) 7 (14.3)
Ex smoker, n (%) 6 (12.2)
History of CAD, n (%) 11 (22.4)
Cirrhosis, n (%) 1 (2)
Renal failure (creatinine > 2 mg/dL), n (%) 6 (12.2)
COPD, n (%) 15 (30.6)
Chronic obstructive arterial disease, n (%) 2 (4.1)
Previous CABG, n (%) 3 (6.1)
Previous PCI, n (%) 19 (38.7)
Previous MI, n (%) 10 (20.4)
Previous TIA, n (%) 6 (12.2)
Previous Stroke, n (%) 4 (8.2)
BMI: body mass index; CAD: coronary artery disease; COPD: chronic
obstructive pulmonary disease; CABG: coronary artery by-pass graft; PCI:
percutaneous coronary intervention; MI: myocardial infarction; TIA: transient
ischemic attack.
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This study adds to the current understanding on ima-
ging appraisal of aortic stenosis with the following
observations: 1) in elderly patients, CMR is feasible in
the majority of cases, despite potential limitations attri-
butable to age and comorbidities. Common reasons for
not undergoing CMR were presence of incompatible
devices, claustrophobia, poor clinical conditions and
severe arrhythmias; 2) when feasible, CMR provided
diagnostic information and adequate sizing in all
patients; conversely, LGE could not be assessed in 6.1%;
Figure 3 Scattered plot of trans-thoracic echocardiography (TTE) and cardiovascular magnetic resonance (CMR). Correlation analysis of
aortic annulus (A), left ventricular outflow tract (LVOT) (B), left ventricular ejection fraction (LVEF) (C) and aortic valve area (AVA) (D) measured by
TTE and CMR.
Table 2 Correlation between TTE and CMR
Regression Equation R
2 P
EDV (ml) y = 10.8264 + 0.6053 x 0.50 < 0.001
ESV (ml) y = 16.0854 + 0.5269 x 0.57 < 0.001
EF (%) y = 23.9774 + 0.4687 x 0.47 < 0.001
LVOT (mm) y = 7.3743 + 0.6149 x 0.62 < 0.001
Ascending aorta (mm) y = 4.4615 + 0.9059 x 0.75 < 0.001
Annulus (mm) y = 7.1490 + 0.6025 x 0.48 < 0.001
Sinus of Valsalva (mm) y = 7.0782 + 0.7619 x 0.58 < 0.001
Sinotubular junction (mm) y = 4.1418 + 0.8444 x 0.59 < 0.001
AVA (cm
2) y = 0.2931 + 0.4723 x 0.24 < 0.001
Peak velocity (m/s) y=2,9956 + 0,4350 x 0.28 < 0.001
TTE: trans-thoracic echocardiography; CMR: cardiovascular magnetic
resonance; EDV: end diastolic volume; ESV: end-systolic volume EF: ejection
fraction; LVOT: left ventricular outflow tract; AVA: aortic valve area.
Table 3 Comparison between TTE and CMR
measurements
TTE CMR P
EDV (ml) 103.6 ± 41.4 153.3 ± 48 < 0.001
ESV (ml) 50.3 ± 29.2 64.9 ± 42 < 0.001
EF (%) 52.1 ± 10.1 60.1 ± 14.8 < 0.001
LVOT (mm) 19.8 ± 2.08 20.3 ± 2.6 < 0.001
Ascending aorta (mm) 35.8 ± 4.1 34.5 ± 3.9 < 0.001
Annulus (mm) 21.4 ± 1.9 23.7 ± 2.2 < 0.001
Sinus of Valsalva (mm) 30.5 ± 3.3 30.7 ± 3.3 < 0.001
Sinotubular junction (mm) 26.3 ± 3.3 26.3 ± 3.0 < 0.001
AVA (cm
2) 0.64 ± 0.17 0.74 ± 0.18 < 0.001
Peak velocity (m/s) 3.9 ± 0.8 4.7 ± 0.6 < 0.001
TTE: trans thoracic echocardiography; CMR: cardiovascular magnetic
resonance; EDV: end diastolic volume; ESV: end-systolic volume; EF: ejection
fraction; LVOT: left ventricular outflow tract; AVA: aortic valve area.
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vide numerically similar measurements in terms of
annulus size, LVOT, and AVA; conversely, CMR gener-
ally detects larger values of LVEF.
In this study, we comprehensively assessed the corre-
lation and agreement of two different imaging methods
in evaluating elderly patients with severe aortic stenosis
referred to TAVI. Importantly, general contraindications
to CMR did not allow the performance of the test in all
screened patients. These inherent limitations, along with
attended costs, suggest that CMR should be used only
in selected cases, especially in case of questionable
results from first-level investigations. Patients submitted
to CMR successfully completed the imaging acquisition
protocol in all cases, despite an average age of 80 years.
In contrast, TTE was not diagnostic in only one patient
due to a poor acoustic window.
Echocardiography is the reference standard for the
initial preoperative evaluation of aortic stenosis. Several
parameters need to be considered in the preoperative
assessment of aortic stenosis patients, including stenosis
degree, various aortic measurements and left ventricular
function [5]. Regarding the aortic gradient assessment,
potential limitations of TTE may result from misalign-
ment of jet and ultrasound beam, recording of mitral
regurgitation jet, neglect of an elevated proximal speed,
or pressure recovery phenomenon [5]. In addition, in
patients with technically limited images from TTE or
TEE, current guidelines recommend characterization of
native and prosthetic cardiac valves, including planime-
try of stenotic disease and quantification of regurgitant
disease by CMR [20]. Reant et al. showed that CMR pla-
nimetry of the AVA is a noninvasive and reproducible
technique to evaluate stenotic aortic valves which can
be used as an alternative to echocardiography or cardiac
catheterisation [21]. Similarly, Pouler et al. proved that
both planimetry and continuity equation-based measure-
ments of AVA by CMR are equally accurate [22]. How-
ever, similar to TEE, CMR-derived AVA is larger by
planimetry than by continuity equation. This is
Figure 4 Agreement of trans-thoracic echocardiography (TTE) and cardiovascular magnetic resonance (CMR) by Bland-Altman analysis.
Bland-Altman analysis for aortic annulus (A), left ventricular outflow tract (LVOT) (B), left ventricular ejection fraction (LVEF) (C) and aortic valve
area (AVA) (D) measured by TTE and CMR.
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mum opening of a stenotic aortic valve is larger than
the size of the functional vein contract [22]. Consistently
with these assumptions, we observed a good correlation
between TTE and CMR, with an absolute mean differ-
ence of 0.10 mm
2 and only a slight tendency to detect
larger areas with CMR.
In patients who are candidate to TAVI, much
emphasis is given to aortic annulus sizing, as it implies
t h ec h o i c eo ft y p ea n ds i z eo ft h ev a l v ep r o s t h e s i s .
Measurements are usually performed with TTE or
TEE, but comparisons between these methods are rare
and controversial [23,24]. Recently, it has been sug-
gested that MSCT could also provide detailed informa-
tion on the shape and length of the aortic annulus
[10], but comparisons between MSCT and echocardio-
graphic measurements are not exhaustive. Messika-Zei-
toun et al. [25] reported that in TAVI patients,
measurements of the aortic annulus using TTE, TEE
and MSCT were close but not identical, and the
method used has important potential clinical implica-
tions on the TAVI strategy. Due to the lack of a gold
standard and waiting for further evidence, a strategy
based on TEE measurements may provide good clinical
results. In this context, CMR may represent a valuable
alternative to both TTE and MSCT, with the advan-
tages of clear visualization of the aorta with freedom
from ionizing radiation and iodinated contrast-induced
effects. Comparative data between CMR and different
imaging techniques in evaluating patients referred to
TAVI are sparse. Koos et al. [26] recently compared
annulus measurements by MSCT, TEE and non-con-
trast-enhanced CMR using navigator-gated 3-D whole-
heart acquisition, showing a good correlation between
MSCT and CMR measurements, while the annulus
diameters assessed by TEE were significantly smaller
than coronal aortic annulus diameters assessed by
CMR. This is consistent with our study, which used a
different CMR protocol, showing that annulus size
adequately correlates with TTE, with an absolute mean
difference of + 2.3 mm. In our study, patients did not
undergo TEE and MSCT and a formal comparison in
terms of feasibility, correlation and agreement with
these techniques is not possible at this time. However,
considering the age of our study patients and the fact
that they have been submitted to a diagnostic examina-
t i o n( C M R )b e i n ga d d e dt oT T E ,w ef e l tt h a tt h e
implementation of further diagnostic second-level tests
(TEE, MSCT) could have limited the compliance of
our enrolled participants. In addition in our centre, as
others centres, the TEE is not used routinely for pre-
and intra-operative evaluation.
CMR is the gold standard for the calculation of ventri-
cular volumes and LVEF, being recommended especially
in cases of heart failure, myocardial infarction, cardio-
myopathy, and particularly in presence of a poor acous-
tic window or discrepancies between different
methodologies [20]. In fact, the accuracy of left ventri-
cular volumes and LVEF with two-dimensional echocar-
diography is limited by image position, geometric
assumption, and boundary tracing errors [27]. In our
study, LVEF and volumes by TTE were significantly
lower than those calculated by CMR. This is probably
due to the limitations listed above that are likely to be
amplified in this patient population (e.g. elderly with
chronic obstructive pulmonary disease, heavy calcifica-
tions and/or unfavorable chest conformation). These
caveats could be addressed by three-dimensional echo-
cardiography, as noted by Jenkins et al. [28]. However,
even three dimensional TTE presents some limitations.
Shimada et al. [29] performed a meta-analysis of studies
comparing left ventricular volumes and or LVEF
between three-dimensional TTE and CMR, showing that
three-dimensional TTE systematically underestimates
these measures in subgroups such as women and
patients with co-existing cardiac disease, whereas use of
semiautomatic tracking and matrix-array transducers is
needed to counteract this underestimation. Given the
above limitations, the usefulness of CMR as an option
to reliably estimate volumes and LVEF in patients
referred to TAVI (e.g. those with low-flow low-gradient
aortic stenosis) is plausible and deserves further
investigation.
Finally, CMR allows a precise definition of the
infarcted areas, if any, and accurate detection of fibro-
sis secondary to aortic stenosis. Weidemann et al.
showed that myocardial fibrosis is an important mor-
phological substrate of unfavorable postoperative clini-
cal outcome in patients with severe aortic stenosis,
which is not reversible after aortic valve replacement
over the 9 months of follow-up and could therefore be
a parameter to be included in a pre-operative assess-
ment of patients [30]. Importantly, in our study, LGE
was present in 37% of cases, including 32.6% of
ischemic type which may have further impact on the
clinical outcome [31].
Conclusions
In elderly patients submitted to TAVI, CMR is feasible
and allows a global appraisal of aortic and ventricular
morphology and function, representing a viable comple-
ment to transthoracic echocardiography. CMR is not
applicable in all patients due to general contraindica-
tions such as claustrophobia and previous implantation
of different devices. Therefore, its performance should
be directed to patients in whom conventional TTE does
not give a sufficient amount of information to drive
decision making in TAVI.
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